Home / Publications

Publications


Media type
Expertise
03/01/2024
CMS Life Sciences & Healthcare Global Brochure
With big deals fuelling record levels of M&A activity, a steady stream of innovative and disruptive technologies, new and increasingly complex regulatory challenges and a thriving start-up community...
12/09/2023
CMS European Class Actions Report 2023
Data-driven insights into class action risk across Europe, a key concern for major corporates
07/07/2022
CMS European Class Actions Report 2022
Data driven insights into  class action risk across Europe, a key concern for major corporates
01/06/2022
CMS Next
What’s next? In a world of ever-ac­cel­er­at­ing change, staying ahead of the curve and knowing what’s next for your business or sector is essential. At CMS, we see ourselves not only as your legal advisers but also as your business partners. We work together with you to not only resolve current issues but to anticipate future challenges and innovate to meet them. With our latest publication, CMS Next, our experts will regularly offer you insights into and fresh perspectives on a range of issues that businesses have to deal with – from ESG agendas to restructuring after the pandemic or facing the digital transformation. We will also share with you more about the work that we are doing for our clients, helping them innovate, grow and mitigate risk. To be able to provide you with the best support, we immerse ourselves in your world to understand your legal needs and challenges. However, it is equally important that you know who we are and how we can work with you. So, we invite you to meet our experts and catch a glimpse of what is happening inside CMS. Enjoy reading this publication, which we will update regularly with new content. CMS Executive Team
24/11/2021
On the Pulse
Welcome to CMS ‘On the Pulse’ video/podcast series for all Life Sciences & Healthcare professionals – legal, compliance, regulatory
16/06/2021
CMS European Class Actions Report 2021
First report on the true picture of European class action risk, a key concern for major corporates 
03/06/2021
The impact of a revolutionary Dutch Climate Change Judgment on companies...
Introduction: revolutionary judgment for multinationals in all sectorsLast week a revolutionary climate change judgment was rendered with potentially great impact on companies worldwide, especially on...
17/06/2020
Podcast: Advertising of Medicines and Medical Devices
The series brings together CMS lawyers and experts to discuss key industry topics impacting, innovating and disrupting the life sciences & healthcare sector.  In Episode #2, Nick Beckett (China/Hong...
04/05/2020
5 misconceptions about the GDPR data breach notification
In 2019, the Dutch Data Protection Authority (DDPA) received 26.956 data breach notifications. The majority of these breaches were notified by organisations active in health sector (mostly hospitals...
17/03/2020
While doctors fight COVID-19 authorities battle fraud, price hikes and...
In every country hit by COVID-19, the disease linked to the Coronavirus, competition and consumer protection authorities have been confronted with the virus's implications. Governments, authorities and...
19/02/2020
CMS Reception in Davos 2020: Oliver Bäte and Werner Baumann
CMS in conjunction with Germany’s leading weekly newspaper Die Zeit, hosted its annual reception in Davos on 22 January. This year the topic was “Challenges and Business Opportunities in the World...
21/01/2020
The intellectual property dilemmas caused by AI-generated works
With the rise of artificial intelligence (AI) in many sectors, questions pop up about the full extent of AI use and its influence on ownership and ac­count­ab­il­ity. In healthcare, AI is used to support...